Bemnifosbuvir, a guanosine analogue, is in clinical trials against the Hepatitis C virus (HCV) and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This compound undergoes a series of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback